Olema Pharmaceuticals, Inc.
Pharmaceutical company · San Francisco, California, United States · Nasdaq: OLMA
Olema Pharmaceuticals, Inc. is a pharmaceutical company headquartered in San Francisco, California, United States. Its shares trade on Nasdaq under the ticker OLMA. It has reported private securities offerings to the US SEC, most recently $250 million sold in a notice filed in 2024.
Olema Pharmaceuticals at a glance
What does Olema Pharmaceuticals do?
Private fundraising reported to the SEC
6 Form D notices; the most recent reported $250 million sold (2024).
Frequently asked questions about Olema Pharmaceuticals
Where is Olema Pharmaceuticals headquartered?
Olema Pharmaceuticals, Inc. is headquartered in San Francisco, California, United States.
What does Olema Pharmaceuticals do?
Olema Pharmaceuticals, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Olema Pharmaceuticals a public company?
Yes. Olema Pharmaceuticals, Inc. trades on Nasdaq under the ticker OLMA.
Similar companies
- Kyntra Bio, Inc.San Francisco, California, United States
- Nektar TherapeuticsSan Francisco, California, United States
- GT Biopharma, Inc.San Francisco, California, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.